DK1220849T3 - Sammensætninger med bicykliske forbindelser og fremgangsmåde til stabilisering heraf - Google Patents

Sammensætninger med bicykliske forbindelser og fremgangsmåde til stabilisering heraf

Info

Publication number
DK1220849T3
DK1220849T3 DK00966462T DK00966462T DK1220849T3 DK 1220849 T3 DK1220849 T3 DK 1220849T3 DK 00966462 T DK00966462 T DK 00966462T DK 00966462 T DK00966462 T DK 00966462T DK 1220849 T3 DK1220849 T3 DK 1220849T3
Authority
DK
Denmark
Prior art keywords
compositions
stabilization method
bicyclic compounds
bicyclic
compounds
Prior art date
Application number
DK00966462T
Other languages
Danish (da)
English (en)
Inventor
Ryuji Ueno
Tsuyoshi Habe
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22573018&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1220849(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sucampo Ag filed Critical Sucampo Ag
Application granted granted Critical
Publication of DK1220849T3 publication Critical patent/DK1220849T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK00966462T 1999-10-15 2000-10-13 Sammensætninger med bicykliske forbindelser og fremgangsmåde til stabilisering heraf DK1220849T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15954999P 1999-10-15 1999-10-15

Publications (1)

Publication Number Publication Date
DK1220849T3 true DK1220849T3 (da) 2004-09-27

Family

ID=22573018

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00966462T DK1220849T3 (da) 1999-10-15 2000-10-13 Sammensætninger med bicykliske forbindelser og fremgangsmåde til stabilisering heraf
DK04005836T DK1426361T4 (en) 1999-10-15 2000-10-13 Novel compounds containing a bi-cyclic compound and a glyceride

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK04005836T DK1426361T4 (en) 1999-10-15 2000-10-13 Novel compounds containing a bi-cyclic compound and a glyceride

Country Status (26)

Country Link
US (5) US6583174B1 (hu)
EP (2) EP1220849B1 (hu)
JP (2) JP4332316B2 (hu)
KR (1) KR100830061B1 (hu)
CN (1) CN1268623C (hu)
AR (3) AR026046A1 (hu)
AT (2) ATE267189T1 (hu)
AU (2) AU780342B2 (hu)
BR (1) BRPI0014869B8 (hu)
CA (1) CA2385732C (hu)
CZ (1) CZ303625B6 (hu)
DE (2) DE60039727D1 (hu)
DK (2) DK1220849T3 (hu)
ES (2) ES2309410T5 (hu)
HK (2) HK1066792A1 (hu)
HU (2) HU230484B1 (hu)
IL (2) IL148803A0 (hu)
MX (1) MXPA02003756A (hu)
NO (1) NO330258B1 (hu)
NZ (1) NZ518020A (hu)
PT (2) PT1426361E (hu)
RU (1) RU2695274C3 (hu)
TR (1) TR200201032T2 (hu)
TW (1) TWI281918B (hu)
WO (1) WO2001027099A2 (hu)
ZA (1) ZA200202312B (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1220849T3 (da) * 1999-10-15 2004-09-27 Sucampo Ag Sammensætninger med bicykliske forbindelser og fremgangsmåde til stabilisering heraf
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
FR2842810B1 (fr) * 2002-07-25 2006-01-27 Inst Nat Sciences Appliq Nouveaux composes gem difluores, leur procedes de preparation et leurs applications.
NZ539582A (en) * 2002-10-23 2007-07-27 Sucampo Ag Prostaglandin compounds for the treatment of obesity
TWI336254B (en) * 2002-12-27 2011-01-21 Sucampo Ag Pharmaceutical composition for treating abdominal discomfort
ATE489096T1 (de) * 2003-07-03 2010-12-15 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
TWI387454B (zh) 2004-09-02 2013-03-01 Sucampo Ag 治療胃腸道疾病之方法及組成物
RU2468800C2 (ru) * 2005-04-12 2012-12-10 Сукампо Аг Комбинированное применение производного простагландина и ингибитора протонового насоса для лечения желудочно-кишечных заболеваний
KR101393944B1 (ko) 2006-01-24 2014-05-12 수캄포 아게 연질-젤라틴 캡슐 제형물
NZ570190A (en) 2006-01-24 2011-03-31 Sucampo Ag Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
KR101353187B1 (ko) * 2006-02-07 2014-01-17 수캄포 아게 프로스타글란딘 유도체의 제조 방법
US20090030072A1 (en) 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
US20090012165A1 (en) 2007-07-03 2009-01-08 Sucampo Ag Pharmaceutical combination of nsaid and prostaglandin compound
CA2691995C (en) * 2007-07-19 2016-04-26 R-Tech Ueno, Ltd. Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
CN101318948B (zh) * 2008-04-01 2011-04-27 上海天伟生物制药有限公司 鲁比前列酮晶体、其制备方法及用途
US8569279B2 (en) * 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
US20110034424A1 (en) * 2009-06-30 2011-02-10 Sucampo Ag Method for the long term nsaid use
HUE028874T2 (hu) 2009-07-28 2017-01-30 Ono Pharmaceutical Co Biciklikus vegyület és annak felhasználása orvosi célokra
BR112012006069A8 (pt) * 2009-09-18 2017-10-10 Adolor Corp Método para tratar ou prevenir constipação induzida e disfunção intestinal induzida por opióide em um humano, e, uso de uma quantidade terapeuticamente efetiva de composto
US8940790B2 (en) 2009-11-03 2015-01-27 Bernard Charles Sherman Stable pharmaceutical formulations comprising lubiprostone
US9150537B2 (en) 2011-01-27 2015-10-06 Ono Pharmaceutical Co., Ltd. Bicyclic compound and use thereof for medical purposes
WO2012102357A1 (ja) 2011-01-27 2012-08-02 小野薬品工業株式会社 二環式化合物およびその医薬用途
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
EP3277274B1 (en) 2015-04-01 2024-06-12 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof
WO2018003945A1 (ja) 2016-06-30 2018-01-04 小野薬品工業株式会社 二環式化合物の製造方法
WO2018065826A1 (en) 2016-10-06 2018-04-12 Sucampo Ag Multilayer beads for pharmaceutical use
WO2019221215A1 (ja) * 2018-05-18 2019-11-21 ニプロ株式会社 ルビプロストン含有粒子状医薬組成物
JP7518661B2 (ja) 2020-05-14 2024-07-18 沢井製薬株式会社 ルビプロストン含有整粒物、ルビプロストン含有錠剤およびそれらの製造方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US18202A (en) * 1857-09-15 Improvement in feathering paddle-wheels
JPS5720305B2 (hu) 1973-02-28 1982-04-27
US4034003A (en) 1974-04-11 1977-07-05 Ono Pharmaceutical Co., Ltd. 15-Cycloalkyl-prostaglandins
US3966962A (en) * 1975-03-27 1976-06-29 The Upjohn Company Triacetin solutions of PGE-type compounds
JPS5350141A (en) * 1976-10-18 1978-05-08 Ono Pharmaceut Co Ltd Stabilization of prostaglandin and prostaglandin analogues
JPS5919524B2 (ja) 1976-12-17 1984-05-07 中外製薬株式会社 安定な１α−ヒドロキシビタミンＤ類含有製剤
JPS5391110A (en) 1977-01-20 1978-08-10 Yamanouchi Pharmaceut Co Ltd Novel drug composition for rectal infusion
CA1184906A (en) * 1977-04-19 1985-04-02 Roy A. Johnson 9-deoxy-5,9-epoxy-prostaglandins
JPS6022708B2 (ja) 1977-07-14 1985-06-03 小野薬品工業株式会社 プロスタグランジン類似化合物
JPS5452717A (en) * 1977-09-29 1979-04-25 Chugai Pharmaceut Co Ltd Stable oily pharmaceuticals containing 1alpha-hydroxyvitamin d
US4130566A (en) * 1977-10-27 1978-12-19 Sumitomo Chemical Company, Limited Process for producing 5-carboxy-2-acetylthiophene
AT358530B (de) 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
JPS55136219A (en) 1979-04-11 1980-10-23 Sumitomo Chem Co Ltd Diazepam oily drug
US4670569A (en) 1981-04-02 1987-06-02 G. D. Searle & Co. 5-fluoro-PGI2 compounds
JPS59137413A (ja) * 1983-01-25 1984-08-07 Teijin Ltd ７−チアプロスタグランジンｅ↓１類を含有する医薬品組成物
US4687864A (en) 1983-12-23 1987-08-18 G. D. Searle & Co. 5-fluoro-3-oxa-prostacyclin compounds
US4579958A (en) 1983-12-23 1986-04-01 G. D. Searle & Co. 5-fluoro-3-oxa-6,7-didehydro-PGI1 compounds
US5428062A (en) 1987-01-28 1995-06-27 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5225439A (en) 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US4758880A (en) 1987-03-27 1988-07-19 The Grass Valley Group, Inc. Video matte generator
DE3851152T2 (de) 1987-09-03 1995-01-26 Univ Georgia Cyclosporin-augenmittel.
US5317032A (en) * 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
GB2210556B (en) 1987-10-02 1991-07-17 Ueno Seiyaku Oyo Kenkyujo Kk The use of 15-keto-16-halo-prostaglandins in cathartic compositions
JP2597649B2 (ja) † 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
KR0158870B1 (ko) * 1988-06-17 1998-12-01 마틴 에이. 로쓰블랫 폐순환 승압의 치료, 예방 또는 진단용 조성물
JP2579193B2 (ja) 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体
JPH0745504B2 (ja) * 1988-07-29 1995-05-17 株式会社上野製薬応用研究所 プロスタグランジン前駆体およびその製法
JP2794433B2 (ja) 1989-02-02 1998-09-03 丸善製薬株式会社 甘草疎水性フラボノイド製剤
CA2030344C (en) † 1989-11-22 2000-04-18 Ryuji Ueno Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
CA2030346C (en) † 1989-11-22 2000-04-11 Ryuji Ueno Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
ATE174221T1 (de) * 1990-05-01 1998-12-15 R Tech Ueno Ltd Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
JPH0446122A (ja) 1990-06-13 1992-02-17 Nippon Iyakuhin Kogyo Kk 活性型ビタミンｄ↓３類含有製剤
CA2046069C (en) 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
JP2938579B2 (ja) 1990-12-15 1999-08-23 株式会社上野製薬応用研究所 消化管壁保護剤
JP2746800B2 (ja) * 1991-09-03 1998-05-06 株式会社アールテック・ウエノ プロスタグランジン中間体の製法
US5274130A (en) * 1991-09-03 1993-12-28 R-Tech Ueno Ltd. Process for production of prostaglandin intermediates
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
US5981607A (en) 1998-01-20 1999-11-09 Allergan Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
DK1220849T3 (da) * 1999-10-15 2004-09-27 Sucampo Ag Sammensætninger med bicykliske forbindelser og fremgangsmåde til stabilisering heraf
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
JP4210631B2 (ja) 2004-06-24 2009-01-21 株式会社日立製作所 ブレーキ制御装置

Also Published As

Publication number Publication date
HK1066792A1 (en) 2005-04-01
JP2003511445A (ja) 2003-03-25
RU2002112984A (ru) 2004-01-20
ES2309410T5 (es) 2015-03-17
AU2004242503B2 (en) 2007-06-21
CZ303625B6 (cs) 2013-01-16
WO2001027099A2 (en) 2001-04-19
NO20021736L (no) 2002-04-12
HU229547B1 (en) 2014-01-28
NZ518020A (en) 2004-02-27
ES2221859T3 (es) 2005-01-16
JP2009235079A (ja) 2009-10-15
RU2695274C2 (ru) 2019-07-22
DE60039727D1 (de) 2008-09-11
US6583174B1 (en) 2003-06-24
AU7685600A (en) 2001-04-23
KR100830061B1 (ko) 2008-05-16
EP1220849A2 (en) 2002-07-10
TR200201032T2 (tr) 2002-08-21
CA2385732C (en) 2009-02-10
DE60010913T2 (de) 2005-06-09
US20080255227A1 (en) 2008-10-16
BRPI0014869B1 (pt) 2017-06-13
US20120095090A1 (en) 2012-04-19
EP1220849B1 (en) 2004-05-19
CN1379769A (zh) 2002-11-13
DK1426361T4 (en) 2015-03-16
HUP0203746A3 (en) 2005-02-28
AR109354A2 (es) 2018-11-21
US20040235885A1 (en) 2004-11-25
BR0014869A (pt) 2002-06-25
BRPI0014869B8 (pt) 2021-05-25
US8088934B2 (en) 2012-01-03
AR026046A1 (es) 2002-12-26
HU230484B1 (hu) 2016-07-28
AU780342B2 (en) 2005-03-17
CZ20021037A3 (cs) 2002-09-11
PT1426361E (pt) 2008-10-08
HUP0203746A2 (hu) 2003-03-28
ATE267189T1 (de) 2004-06-15
EP1426361B2 (en) 2015-02-25
RU2695274C9 (ru) 2020-01-22
CA2385732A1 (en) 2001-04-19
MXPA02003756A (es) 2005-09-08
ATE402925T2 (de) 2008-08-15
AR089848A2 (es) 2014-09-24
ZA200202312B (en) 2002-12-24
HK1045693B (zh) 2005-01-21
AU2004242503A1 (en) 2005-01-27
KR20020068521A (ko) 2002-08-27
NO330258B1 (no) 2011-03-14
IL148803A0 (en) 2002-09-12
US7417067B2 (en) 2008-08-26
EP1426361A1 (en) 2004-06-09
CN1268623C (zh) 2006-08-09
WO2001027099A3 (en) 2001-10-25
DE60010913D1 (de) 2004-06-24
AU2004242503C1 (en) 2005-01-27
RU2695274C3 (ru) 2020-11-09
NO20021736D0 (no) 2002-04-12
EP1426361B1 (en) 2008-07-30
IL148803A (en) 2006-07-05
HUP1300369A2 (hu) 2003-03-28
DK1426361T3 (da) 2008-11-17
HK1045693A1 (en) 2002-12-06
JP4332316B2 (ja) 2009-09-16
US8097649B1 (en) 2012-01-17
PT1220849E (pt) 2004-10-29
TWI281918B (en) 2007-06-01
ES2309410T3 (es) 2008-12-16

Similar Documents

Publication Publication Date Title
DK1220849T3 (da) Sammensætninger med bicykliske forbindelser og fremgangsmåde til stabilisering heraf
DK1242095T3 (da) Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf
DK1813624T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi
NO20012940D0 (no) Fremgangsmåter og sammensetninger for å redusere permeabilitetene til underjordiske soner
DK1121192T3 (da) Fremgangsmåde til homogenisering
NO20000011D0 (no) Skumdempersammensetninger og fremgangsmåter
DE60132732D1 (de) Primerzusammensetzung und Verbindungsverfahren
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
NO20041975L (no) Bicyklisk oksopyridin og oksopyrimidinderivater
ID29021A (id) Komposisi galantamina pelepasan terkontrol
NO20040873L (no) Fremgangsmate og anordning for sammensetting av gjenfestbare absorberende klesplagg
IS6304A (is) Kínasólínefnasambönd og lyfjafræðilegar efnasamsetningar sem innihalda þau
EP1426349A4 (en) ADDITIVE FOR CEMENT AND CEMENT CONTAINING SAME
NO20021382L (no) Fremgangsmåter og mikroorganismer for fremstilling av panto- forbindelser
DK1339292T3 (da) Sammensætning og fremgangsmåde
DK199900234U4 (da) Paroxetin-methansulfonat i krystallinsk form, farmaceutisk præparat indeholdende dette og andvendelse af forbindelsen til f
AU2003256805A8 (en) Compounds compositions and methods
NO20041004L (no) Fremgangsmate og anordning for sammensetting av gjenfestbare absorberende klesplagg
DE69943245D1 (de) Gaserzeugende zusammensetzung
NO20015772L (no) Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom
ID28577A (id) Metoda pemilihan waktu kalibrasi
AU1435702A (en) Multifunctional water-treating composition and method of water-treating using the same
AU2003297612A8 (en) 2-substituted-3-propenamide derivatives and methods of using the same
ID28764A (id) Metode penstabilan senyawa n-oksil dalam senyawa vinil
DK1228026T3 (da) 15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse